Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.59 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.58 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.58 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.57 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.57 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.57 |
| ▸ | S1PR4 | O95977 | 4/20 | 0.57 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.55 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | GMNN | O75496 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | THPO | P40225 | 1/20 | 0.46 |
| ▸ | MTOR | P42345 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12534568 | 1.00 | ALDH1A1 (0.59) | ALDH1A1PLA2G1BPLA2G2AS1PR2S1PR1 | |
| SCHEMBL6900427 | 1.00 | ALDH1A1 (0.59) | ALDH1A1PLA2G1BPLA2G2AS1PR2S1PR1 | |
| SCHEMBL15888354 | 1.00 | ALDH1A1 (0.59) | ALDH1A1PLA2G1BPLA2G2AS1PR2S1PR1 | |
| SCHEMBL14406883 | 1.00 | ALDH1A1 (0.59) | ALDH1A1PLA2G1BPLA2G2AS1PR2S1PR1 | |
| SCHEMBL14364607 | 1.00 | ALDH1A1 (0.59) | ALDH1A1PLA2G1BPLA2G2AS1PR2S1PR1 | |
| SCHEMBL2667087 | 1.00 | ALDH1A1 (0.59) | ALDH1A1PLA2G1BPLA2G2AS1PR2S1PR1 | |
| SCHEMBL8019781 | 1.00 | ALDH1A1 (0.59) | ALDH1A1PLA2G1BPLA2G2AS1PR2S1PR1 | |
| SCHEMBL10953504 | 1.00 | ALDH1A1 (0.59) | ALDH1A1PLA2G1BPLA2G2AS1PR2S1PR1 | |
| SCHEMBL3236786 | 1.00 | ALDH1A1 (0.59) | ALDH1A1PLA2G1BPLA2G2AS1PR2S1PR1 | |
| SCHEMBL3245584 | 1.00 | ALDH1A1 (0.59) | ALDH1A1PLA2G1BPLA2G2AS1PR2S1PR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1796398-B | Method for extracting nucleic acid by amine surfactant | IND TECH INST | 2012-09-26 | — | — | CN | claimed |
| CN-100494373-C | Method for preserving nucleic acid samples | IND TECH RES INST (CN) | 2009-06-03 | — | — | CN | claimed |
| CN-1796398-A | Method for extracting nucleic acid by amine surfactant | IND TECH INST (CN) | 2006-07-05 | — | — | CN | claimed |
| CN-1796399-A | Method for preserving nucleic acid samples | IND TECH INST (CN) | 2006-07-05 | — | — | CN | claimed |
| EP-1002536-A2 | 2-Amino, 4-alkylamino pyrimidine 3-oxydes as soothing agents for the skin | L'OREAL (FR) | 2000-05-24 | — | — | EP | claimed |
| EP-0974586-A1 | 2-amino-4-alkylamino-pyrimidine 3-oxydes and compositions containing same | L'OREAL (FR) | 2000-01-26 | — | — | EP | claimed |
| CN-107835638-B | Comprising cyclohepta herb Ether and acetochlor or pretilachlor weeding composition | 巴斯夫农业公司 | 2024-12-31 | — | — | CN | disclosed |
| CN-107846890-B | Herbicidal composition comprising cycloheptane and a specific phytoene desaturase inhibitor | 巴斯夫农业公司 | 2024-09-03 | — | — | CN | disclosed |
| CN-107846887-B | Herbicidal composition comprising clomazone and flufenacet | 巴斯夫农业公司 | 2023-12-15 | — | — | CN | disclosed |
| US-20230285628-A1 | HEMOSTATIC DRESSING AND METHOD FOR MANUFACTURING THE SAME | INNOTHERAPY INC. (KR) | 2023-09-14 | — | — | US | disclosed |
| CN-114072000-A | Molecules having certain pesticidal effects and intermediates, compositions and methods related thereto | 科迪华农业科技有限责任公司 | 2022-02-18 | — | — | CN | disclosed |
| US-20200231829-A1 | METHODS AND COMPOSITIONS FOR MAGNETIZABLE PLASTICS | MAGNOMER, INC. | 2020-07-23 | — | — | US | disclosed |
| CN-105175754-B | Polymer-clay nanocomposites and preparation method thereof | 埃克森美孚化学专利公司 | 2019-04-19 | — | — | CN | disclosed |
| CN-100494373-C | Method for preserving nucleic acid samples | IND TECH RES INST (CN) | 2009-06-03 | — | — | CN | disclosed |
| US-20080300412-A1 | Chemical Process for the Preparation of an Amido-Phenoxybenzoic Acid Compound | ASTRAZENECA AB (SE) | 2008-12-04 | — | — | US | disclosed |
| WO-2007075895-A2 | HETEROCYCLIC DERIVATIVES AS MODULATORS OF ION CHANNELS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2007-07-05 | — | — | WO | disclosed |
| CN-1796398-A | Method for extracting nucleic acid by amine surfactant | IND TECH INST (CN) | 2006-07-05 | — | — | CN | disclosed |
| CN-1796399-A | Method for preserving nucleic acid samples | IND TECH INST (CN) | 2006-07-05 | — | — | CN | disclosed |
| EP-1002536-A2 | 2-Amino, 4-alkylamino pyrimidine 3-oxydes as soothing agents for the skin | L'OREAL (FR) | 2000-05-24 | — | — | EP | disclosed |
| EP-0974586-A1 | 2-amino-4-alkylamino-pyrimidine 3-oxydes and compositions containing same | L'OREAL (FR) | 2000-01-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080300412-A1 | Chemical Process for the Preparation of an Amido-Phenoxybenzoic Acid Compound | GCK, HK1, PCK1 | ALDH1A1 646/4885PLA2G1B 1306/4885PLA2G2A 2464/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.